Inactive Instrument

News Foamix Pharmaceuticals Ltd. Nasdaq

Equities

IL0011334385

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : VYNE Therapeutics Inc. - Special Call	04-04
VYNE Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference	03-19	AQ
VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
VYNE Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q4 Revenue $76,000	02-29	MT
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update	02-29	AQ
VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium	02-27	AQ
VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	02-21	AQ
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo	01-10	AQ
VYNE Therapeutics Inc. Announces Positive Biomarker Data from Successful Phase 1B Trial of VYN201 for the Treatment of Vitiligo	01-10	CI
VYNE Therapeutics Inc. Appoints Christine Borowski, Ph.D., to Its Board of Directors	01-03	CI
VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors	01-03	AQ
Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q3 Revenue $114,000	11-13	MT
VYNE Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update	11-13	AQ
Transcript : VYNE Therapeutics Inc. - Special Call	11-09
VYNE Therapeutics to Host Virtual R&D Day Event on November 9, 2023	11-07	AQ
VYNE Therapeutics Announces Closing of Previously Announced Private Placement of $88.2 Million	11-01	AQ
VYNE Therapeutics Inc. announced that it has received $88.151509 million in funding from Acorn Bioventures, Parkman Healthcare Partners LLC, Soleus Capital, Surveyor Capital Management, Palo Alto Investors LP and other investors	10-31	CI
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting	23-10-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Foamix Pharmaceuticals Ltd. Nasdaq

Equities

IL0011334385

Summary

Filters